Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$16.35
+1.43%
Mkt Cap $1.47B
Analyst Ratings
Buy
17
Hold
2
Sell
0
Price Target (33 analysts)
$42.67
Range $31.00 – $50.00
Implied Upside
+161.0%
Consensus $42.67 vs current $16.35
NASDAQ·Healthcare·Biotechnology
$16.35
+1.43%
Mkt Cap $1.47B
Buy
17
Hold
2
Sell
0
Price Target (33 analysts)
$42.67
Range $31.00 – $50.00
+161.0%
Consensus $42.67 vs current $16.35